This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 594| Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
|---|---|---|---|---|---|---|---|---|---|
| 2251 | CXCL10 | RNAs | Human | Upregulated in HCC than CHC and normal (with nearly 13 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
| 2252 | CYP3A4 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 42 and 50 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
| 2253 | CYP4A11 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 17 and 30 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
| 2254 | SLC22A1 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 8 and 17 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
| 2255 | Enoyl-CoA hydratase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15221772 |
| 2256 | Tropomyosin-beta-chain | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
| 2257 | Ketohexokinase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
| 2258 | Liver type aldolase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15221772 |
| 2259 | Arginase 1 | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
| 2260 | CDK4 | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2261 | Bax | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2262 | NOTCH4 | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2263 | ISGF3G | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2264 | TNF | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2265 | VISA | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
| 2266 | AURKB-Sv2 variant | RNAs | Human | Upregulated in metastatic HCC than primary HCC and Absent in normal | Prognostic | Metastatic HCC v/s Primary HCC; correlated with a poor outcome and short disease-free period | p < 0.01 | Cell line and Tissue | 19134008 |
| 2267 | SPP1 | RNAs and Protein | Human | Upregulated in PT than PN (with 3 fold change) | Diagnostic | Metastatic HCC v/s Primary HCC | p < 0.01 | Tissue | 12640447 |
| 2268 | LIMK1, CENPE, FZD2, ENO2, ITGA9, COPA, KIAA0660, GTF2H1, VPS41, RGS20, MATK, STOML1, BASP1, EPB42, ALDH3B2, MEL, CAT56, RAB3A, PSCD3, PLD2, ADCYAP1R1, ALDH3B1, RHD, CSF3R, KIAA0063, KIAA0296, LRP6, ENO3, CTRB1, YES1, IncytePD:1404153, GYS1, MDFI, GABRE, IncytePD:2685601, CD3Z, DTYMK, SPTBN2, IncyteP | RNAs | Human | Upregulated in PT than PN (with 3 fold change) | Diagnostic | Metastatic HCC v/s Primary HCC | p < 0.01 | Tissue | 12640447 |
| 2269 | Phosphoserine aminotransferase | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 3.8) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2270 | IFP53/Tryptophanyl-Trna synthetase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.27) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2271 | Peroxiredoxin 3 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.82) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2272 | GRP94 (Tumor rejection antigen 1) | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.59) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2273 | Annexin A1 (Phospholipase A2 inhibitory protein) | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.52) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2274 | Superoxide dismutase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.44) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2275 | Annexin A2 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.42) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2276 | Annexin A4 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.6) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2277 | L-lactate dehydrogenase B chain | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.61) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2278 | Cyclophilin B (Peptidyl-prolyl cis-trans isomerase B) | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.53) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2279 | ORP150 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.59) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2280 | Vinculin | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.82) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2281 | Flavin reductase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.52) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2282 | Stathmin | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.56) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2283 | Protein kinase C inhibitor protein-1 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 2.7) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2284 | Heterogeneous nuclear ribonucleoprotein A2/B1 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.55) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2285 | 26S proteasome non-ATPase regulatory subunit 8 | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2286 | Glutamine amidotransferase | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.69) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2287 | Phosphoglycerate kinase 1 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.57) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2288 | TCP-1 chaperonin cofactor A | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.57) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2289 | TCP-1-gamma | Protein | Human | Downregulated in recurrence HCC than non-recurrence HCC (with fold change 0.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2290 | Multidrug resistance-associ ated protein MGr1-Ag | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.51) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2291 | Nuclear chloride ion channel 27 | Protein | Human | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.64) | Prognostic | Early recurrence v/s No recurrence HCC | p < 0.05 | Tissue | 17391314 |
| 2292 | RPS5 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 6.35) and (v/s HCV associated HCC with ratio of 2.38) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2293 | KRT8 | RNAs | Human | Upregulated in HBV associated HCC ( v/s normal with fold change 5.68) and (v/s HCV associated HCC with ratio 3.19) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2294 | CFLAR | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 2.86) and (v/s HCV associated HCC with ratio of 2.09) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2295 | ATP5F1 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 4.19) and (v/s HCV associated HCC with ratio of 3.52) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2296 | IGFBP2 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 3.37) and (v/s HCV associated HCC with ratio of 2.49) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2297 | MAP3K5 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 3.76) and (v/s HCV associated HCC with ratio of 2.33) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2298 | MMP9 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 7.43) and (v/s HCV associated HCC with ratio of 3.74) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2299 | VIM | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 8.61) and (ratio of HBV-HCC v/s HCV-HCC 0.28) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |
| 2300 | ACTB | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 4.13) and (ratio of HBV-HCC v/s HCV-HCC 0.37) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |